Granules India gets shareholders nod for acquisition of Auctus Pharma

07 Dec 2013 Evaluate

Granules India, a fast growing pharmaceutical manufacturer has received the shareholders approval for the proposed acquisition of Auctus Pharma, a manufacturer of Active Pharmaceutical Ingredients (APIs). The company has earlier on November 5, 2013 signed a definite agreement for the acquisition of Auctus Pharma.

The board was also authorized to mortgage/charge assets of the company for an amount not exceeding Rs 750 crore.

Granules India is a fast growing pharmaceutical manufacturing company with world class facilities and is committed to manufacturing excellence, quality and customer service. The Company produces Finished Dosages (FDs), Pharmaceutical Formulation Intermediates (PFIs) and Active Pharmaceutical Ingredients (APIs) for quality conscious customers in the regulated and semi-regulated markets.

Granules India Share Price

560.65 -5.90 (-1.04%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×